How Investors Are Reacting To DaVita (DVA) Kidney Week Research Push

DaVita reached a settlement of up to US$15,000,000 related to a 2025 ransomware incident and is preparing to showcase seven kidney care studies at ASN Kidney Week 2026, covering dialysis modalities, home-based treatments and patient experience. The combination of legal cleanup around the cyberattack and DaVita’s broad research presence at a major nephrology meeting highlights how cyber risk management and clinical evidence generation both contribute to the company’s operating reality and...